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Clinics and pathology 
Disease 
De novo ANLL; (one case of blast crisis CML). 
Phenotype / cell stem origin 
Mainly M2 or M4, but also M1, M5a, M5b, or M7 
ANLL; may be preceded by MDS. 
Epidemiology 
About 30 reported cases, mainly found in young adults; 
children cases are described; median age is about 30 
yrs; balanced sex ratio. 
Clinics 
Blood data: anemia, thrombocytopenia, mild 
hyperleucocytosis; with high monocytic cell count at 
times. 
Cytology 
Myelocytic and monocytoid features are often present; 
eosinophils in the bone marrow are sometimes 
abnormal and/or elevated; erythrophagocytosis may be 
found. 
Prognosis 
Seems poor: complete remission may not be achieved; 
there is high incidence of relapse within a year and  




Rarely found solely; most often associated with various 
numerical or structural abnormalities; trisomy 10 was 
found in 4 of 17 cases. 









5' FUS - 3' ERG 
Fusion protein 
Description 
N-term FUS RNA binding domain fused to the C-term 
DNA binding ETS domain of ERG. 
Oncogenesis 
Seems to act as a transcriptional activator. 
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